A detailed history of Rakuten Securities, Inc. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rakuten Securities, Inc. holds 5 shares of MDGL stock, worth $1,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Holding current value
$1,554
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$212.22 - $292.96 $1,061 - $1,464
5 New
5 $1.06 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.32B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Rakuten Securities, Inc. Portfolio

Follow Rakuten Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rakuten Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rakuten Securities, Inc. with notifications on news.